<?xml version="1.0" encoding="UTF-8"?>
<p>In 1999, Australia was one of the first countries to implement and subsequently refine their national hepatitis C strategies and has since then become a best practice model for hepatitis C elimination. Key to Australia's response, including achieving universal treatment access (described below), has been strong community advocacy, health research, health sector and political leadership that foster continued commitment to the WHO 2030 elimination targets, including a timely response to new challenges.
 <xref rid="liv14222-bib-0090" ref-type="ref">90</xref> Australia has had a long and sustained harm reduction approach to injecting drug use, with engagement of civil society, the health sector and government. This is beneficial in reducing bloodborne virus transmission and cultivates a point of engagement with PWID in providing health and social services.
 <xref rid="liv14222-bib-0059" ref-type="ref">59</xref>, 
 <xref rid="liv14222-bib-0060" ref-type="ref">60</xref>, 
 <xref rid="liv14222-bib-0061" ref-type="ref">61</xref>, 
 <xref rid="liv14222-bib-0091" ref-type="ref">91</xref> Strong engagement with PWID is crucial to Australia's response.
</p>
